KASPER; Marc-Andre
Patent Applications and Registrations
Patent applications and USPTO patent grants for KASPER; Marc-Andre.The latest application filed is for "cd30 targeting antibody drug conjugates and uses thereof".
- KASPER; Marc-Andre - Berlin DE
- KASPER; Marc-Andre - Munchen DE
| Patent | Date |
|---|---|
| Cd30 Targeting Antibody Drug Conjugates And Uses Thereof App 20220193251 - LEONHARDT; Heinrich ; et al. | 2022-06-23 |
| Chemoselective Thiol-conjugation With Alkene Or Alkyne-phosphonamidates App 20220106356 - Hackenberger; Christian ; et al. | 2022-04-07 |
| Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates Grant 11,161,873 - Hackenberger , et al. November 2, 2 | 2021-11-02 |
| Chemoselective Thiol-conjugation With Alkene Or Alkyne-phosphonothiolates And - Phosphonates App 20200390901 - HACKENBERGER; Christian ; et al. | 2020-12-17 |
| Chemoselective Thiol-conjugation With Alkene Or Alkyne-phosphonamidates App 20190330264 - Hackenberger; Christian ; et al. | 2019-10-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 